Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Gennery

Showing results (281-290 of 297) with videos related to

Pageof 30
Sort By:
The Journal of Allergy and Clinical Immunology|February 18, 2010
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndromeCristina Woellner, E Michael Gertz, Alejandro A Schäffer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 5, 2018
Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 DeficiencySusanne E Aydin, Alexandra F Freeman, Waleed Al-Herz, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2019
Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) scoreVictoria Katharina Tesch, Hassan Abolhassani, Bella Shadur, et al.
The Journal of Allergy and Clinical Immunology|May 25, 2021
International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndromeDimana Dimitrova, Zohreh Nademi, Maria Elena Maccari, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
The Journal of Allergy and Clinical Immunology|October 31, 2021
Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohortArjan C Lankester, Benedicte Neven, Nizar Mahlaoui, et al.
The Journal of Allergy and Clinical Immunology|September 27, 2020
Coronavirus disease 2019 in patients with inborn errors of immunity: An international studyIsabelle Meyts, Giorgia Bucciol, Isabella Quinti, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2015
The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiencyKarin R Engelhardt, Michael E Gertz, Sevgi Keles, et al.
Blood|April 5, 2024
Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survivalTanja C Vallée, Jannik S Glasmacher, Hannes Buchner, et al.
Pageof 30

Showing results (281-290 of 297) with videos related to

Sort By:
Pageof 30
The Journal of Allergy and Clinical Immunology|February 18, 2010
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndromeCristina Woellner, E Michael Gertz, Alejandro A Schäffer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 5, 2018
Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 DeficiencySusanne E Aydin, Alexandra F Freeman, Waleed Al-Herz, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2019
Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) scoreVictoria Katharina Tesch, Hassan Abolhassani, Bella Shadur, et al.
The Journal of Allergy and Clinical Immunology|May 25, 2021
International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndromeDimana Dimitrova, Zohreh Nademi, Maria Elena Maccari, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
The Journal of Allergy and Clinical Immunology|October 31, 2021
Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohortArjan C Lankester, Benedicte Neven, Nizar Mahlaoui, et al.
The Journal of Allergy and Clinical Immunology|September 27, 2020
Coronavirus disease 2019 in patients with inborn errors of immunity: An international studyIsabelle Meyts, Giorgia Bucciol, Isabella Quinti, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2015
The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiencyKarin R Engelhardt, Michael E Gertz, Sevgi Keles, et al.
Blood|April 5, 2024
Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survivalTanja C Vallée, Jannik S Glasmacher, Hannes Buchner, et al.
Pageof 30